Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Apollo Medical Holdings operates as a physician-centric integrated healthcare delivery platform primarily in California, managing risk-based capitated contracts through affiliated medical groups and Independent Practice Associations (IPAs). The company serves approximately 1.4 million patients through value-based care arrangements with commercial and government payors, generating revenue through capitation payments and shared savings arrangements. Stock performance is driven by membership growth, medical cost ratio management, and regulatory changes affecting Medicare Advantage and Medicaid managed care.
Apollo operates under full-risk capitation arrangements where it receives fixed per-member-per-month payments from health plans and assumes responsibility for all medical costs. Profitability depends on managing medical loss ratios below capitation rates through care coordination, utilization management, and preventive care programs. The company's competitive advantage lies in its physician alignment model, proprietary care management technology, and concentration in Southern California where it has established payor relationships and provider networks. Operating leverage comes from spreading fixed infrastructure costs across growing membership base.
Medicare Advantage membership growth and retention rates in California markets
Medical loss ratio performance relative to capitation rate adequacy
CMS Star Ratings for affiliated health plans affecting bonus payments and member attribution
California Medicaid (Medi-Cal) rate adjustments and managed care contract renewals
Regulatory changes to Medicare Advantage risk adjustment methodology or benchmark rates
CMS policy changes to Medicare Advantage risk adjustment methodology reducing revenue per member by 3-5% annually through coding intensity caps
California Medicaid managed care consolidation reducing payor diversity and negotiating leverage for IPAs
Shift toward direct contracting between health plans and hospital systems bypassing physician intermediaries
Regulatory scrutiny of private equity-backed physician practice management companies affecting valuation multiples and exit opportunities
Large integrated delivery systems (Kaiser, Optum) with employed physician models competing for same Medicare Advantage lives in California
Health plan vertical integration acquiring physician groups directly rather than contracting through management companies
Technology-enabled primary care disruptors (Oak Street Health, ChenMed) expanding in Southern California with superior care management platforms
Debt/equity ratio of 1.40 with minimal free cash flow generation limits financial flexibility for growth investments or adverse medical cost development
Negative net income growth (-28.9%) despite strong revenue growth suggests margin compression from elevated medical costs or integration expenses
Working capital pressure from claims payable timing and potential risk adjustment payment disputes with CMS or health plans
Goodwill and intangible assets from physician practice acquisitions vulnerable to impairment if membership attrition or margin deterioration occurs
low - Healthcare utilization and government-funded insurance programs are relatively recession-resistant. Medicare Advantage enrollment tends to grow during economic downturns as retirees seek cost savings. However, Medicaid eligibility expansions during recessions can increase membership but at lower reimbursement rates. The 46.7% revenue growth suggests recent membership expansion possibly tied to post-pandemic Medicaid continuous coverage unwinding.
Rising rates moderately pressure valuation multiples for healthcare services stocks trading at growth premiums, though Apollo's 0.3x P/S ratio suggests value positioning. Higher rates increase borrowing costs for the 1.40 debt/equity ratio, impacting acquisition financing and working capital management. The company likely maintains claims reserves and capitation prepayments in short-duration investments where rising rates provide modest income benefit. Rate environment affects M&A activity in physician practice consolidation space.
Moderate exposure through payor counterparty risk and claims payment timing. Apollo depends on timely capitation payments from health plans and government programs. Tightening credit conditions could stress smaller regional health plans, though major MA carriers (UnitedHealth, Humana, Anthem) represent lower default risk. The 1.40 current ratio and minimal free cash flow ($0.0B) suggest limited financial flexibility if payors delay payments or dispute risk adjustment settlements.
value - The 0.3x P/S and 1.2x P/B ratios suggest deep value positioning despite 46.7% revenue growth. Investors are likely focused on turnaround potential from margin improvement as recent acquisitions integrate and medical cost ratios normalize. The 6.9% one-year return with 36.3% six-month surge indicates event-driven interest, possibly from operational improvements or M&A speculation. Low institutional ownership typical of small-cap healthcare services creates volatility and liquidity constraints.
high - Small-cap healthcare services stocks with $1.8B market cap experience elevated volatility from quarterly earnings surprises, regulatory announcements, and M&A speculation. Medical loss ratio variability creates earnings unpredictability. The 36.3% six-month return followed by modest one-year performance demonstrates momentum-driven trading patterns. Limited analyst coverage and float concentration amplify price swings on material news.
